Allergy Therapeutics plc

1.27pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:AGYHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (18.86%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.98
PE TTM —
TSR TTM (85.26%)
Mkt cap £80.74M
ROIC (163.21%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
1.63p
27.90%
3.29%
Hold 10|12|12|2|12
2Q26
3Q26
4Q26
1Q27
Earnings per share£
0.01
0.01
0.02
0.02
11.39%
4.53%
11.01%
14.08%
Revenue£M
9.041
9.359
9.806
10.10
9.17%
10.95%
10.94%
13.54%
Peers (US$110.3M)
Cap (US$)
PE
76.13M
26.51x
29.20M
—
110.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.520
0.177
0.157
EBIT/Intx
8.269
0.942
0.988
Own earn%
141.49
(14.67)
(14.59)
Sh yield%
45.31
50.93
52.53
Owners
Insiders/Inst%
2.89
21.94
Short interest%
1.32
SBC / revenue%
5.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
15–22
$1 testx
0.0
Incr. ROIC%
2